# REALM THERAPEUTICS PLC (RLM)

> Institutional ownership reported to the SEC as of Q2 2019, from Form 13F filings. Source: https://holderbook.com/stocks/RLM/

- Reporting holders: 7
- Reported value: $5.9M
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [ORBIMED ADVISORS LLC](https://holderbook.com/funds/1055951-orbimed-advisors-llc/) | $2.9M | 1,021,484 | 0.0% | 3 |
| [BVF INC/IL](https://holderbook.com/funds/1056807-bvf-inc-il/) | $2.6M | 909,759 | 0.3% | 3 |
| [Polar Capital LLP](https://holderbook.com/funds/1439303-polar-capital-llp/) | $351.0K | 124,900 | 0.0% | 1 |
| [CITADEL ADVISORS LLC](https://holderbook.com/funds/1423053-citadel-advisors-llc/) | $46.0K | 16,176 | 0.0% | 1 |
| [HSBC HOLDINGS PLC](https://holderbook.com/funds/873630-hsbc-holdings-plc/) | $43.0K | 15,222 | 0.0% | 2 |
| [UBS Group AG](https://holderbook.com/funds/1610520-ubs-group-ag/) | $7.0K | 2,558 | 0.0% | 3 |
| [PIPER JAFFRAY & CO.](https://holderbook.com/funds/724683-piper-jaffray-co/) | $2.0K | 611 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2019 | 7 | $5.9M |
| Q1 2019 | 8 | $9.6M |
| Q4 2018 | 4 | $2.6M |